-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Tuberculosis, commonly known as tuberculosis, is a fatal disease caused by Mycobacterium tuberculosis (TB bacterium for short), and pulmonary tuberculosis is the most common
This vaccine, called RdrBCG (recombinant drug-resistant BCG), is based on the familiar BCG vaccine
Animal research results show that both RdrBCG-I and wild BCG show strong safety in mice with severe immunodeficiency
RdrBCG provides a new design concept for the design of therapeutic vaccines against Mycobacterium tuberculosis and other refractory pathogens
The paper is listed as the first author Dr.
Paper link
Guangzhou Health Institute confirms that the modified BCG vaccine can assist in the treatment of drug-resistant tuberculosis